US OptionsDetailed Quotes
HIMS241011P19000
- 1.50
- -0.76-33.63%
15min DelayClose Oct 4 16:00 ET
2.25High1.50Low
2.00Open2.26Pre Close13 Volume19 Open Interest19.00Strike Price2.52KTurnover78.54%IV0.91%PremiumOct 11, 2024Expiry Date1.34Intrinsic Value100Multiplier4DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type-0.7921Delta0.1920Gamma11.77Leverage Ratio-0.0491Theta-0.0016Rho-9.33Eff Leverage0.0055Vega
Hims & Hers Health Stock Discussion
Sign in to post a comment
Morning Movers
Gapping up
$Pfizer (PFE.US)$ stock increased by 3.4% following a Bloomberg report that activist investor Starboard Value acquired approximately $1 billion in shares of the pharmaceutical giant, aiming to drive a turnaround for the company.
$Hims & Hers Health (HIMS.US)$ saw its stock rise by 5.4% after it was announced that the telehealth company would be joining the S&P SmallCap 600, replacing Vector Group, the...
Gapping up
$Pfizer (PFE.US)$ stock increased by 3.4% following a Bloomberg report that activist investor Starboard Value acquired approximately $1 billion in shares of the pharmaceutical giant, aiming to drive a turnaround for the company.
$Hims & Hers Health (HIMS.US)$ saw its stock rise by 5.4% after it was announced that the telehealth company would be joining the S&P SmallCap 600, replacing Vector Group, the...
29
1
$Hims & Hers Health (HIMS.US)$ guess what is the price by end of this week?
$Hims & Hers Health (HIMS.US)$ If you didn’t hop in yesterday, you’re missing out on some profits tbh. Yesterday was a solid entry point. Target’s still set at 20.5, with a good entry around 17.3 - .5
$Hims & Hers Health (HIMS.US)$
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
1
Morning Movers
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
30
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Here are 3 stocks that I don’t see talked about that I believe deserve more attention, because they have impressed me! Like Cloudflare Stock, did you know 16% of global internet traffic goes throgh cloudflare in one way or another! Plus Docusign and HIMS are both debt free! i show you how many shares i got & how much im up/down on these!
$Cloudflare (NET.US)$ $Hims & Hers Health (HIMS.US)$ $DocuSign (DOCU.US)$ $Invesco QQQ Trust (QQQ.US)$
$Cloudflare (NET.US)$ $Hims & Hers Health (HIMS.US)$ $DocuSign (DOCU.US)$ $Invesco QQQ Trust (QQQ.US)$
From YouTube
2
No comment yet
104556909 : good